title: [Hormones and mammographic breast density].
abstract: Breast constitutional density may be altered and increased (acquired density) by hormonal interventions such as hormone replacement therapy (HRT). The effects of endogenous (steroids, prolactin, insulin-like factors...) and exogenous (HRT, levonorgestrel IUD, tibolone, tamoxifen, SERMs) hormones will be reviewed. Continuous combined estrogen-progestin preparations are most likely to cause an increase in density. Estrogen alone and tibolone are less likely to cause an increase in density. The sensitivity and specificity of mammography are decreased, with increased risk of interval carcinoma and rate of short interval follow-up from false positive results. The issue with regards to interruption of the hormonal therapy prior to mammography, and the duration of the interruption, are discussed.
authors.affiliation: Service de Radiologie, CHU Saint-André, 1 rue Jean Burguet, 33075 Bordeaux cedex, France. martine.boisserie-lacroix@chu-bordeaux.fr
authors.forename: M
authors.initials: M
authors.lastname: Boisserie-Lacroix
authors.forename: N
authors.initials: N
authors.lastname: Lebiez-Michel
authors.forename: P
authors.initials: P
authors.lastname: Cavagni
authors.forename: J
authors.initials: J
authors.lastname: Bentolila
authors.forename: H
authors.initials: H
authors.lastname: Laumonier
authors.forename: M
authors.initials: M
authors.lastname: Bouzgarrou
authors.forename: H
authors.initials: H
authors.lastname: Trillaud
mesh_terms: D000328:Adult; D000368:Aged; D001706:Biopsy; D001940:Breast / Q000187:drug effects / Q000473:pathology; D001943:Breast Neoplasms / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000473:pathology; D003271:Contraceptive Agents, Female / Q000494:pharmacology; D003937:Diagnosis, Differential; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D005260:Female; D012739:Gonadal Steroid Hormones / Q000502:physiology; D006728:Hormones / Q000502:physiology*; D006801:Humans; D007434:Intrauterine Devices; D016912:Levonorgestrel / Q000494:pharmacology; D008327:Mammography; D008593:Menopause; D008597:Menstrual Cycle; D008875:Middle Aged; D009652:Norpregnenes / Q000494:pharmacology; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D020845:Selective Estrogen Receptor Modulators / Q000494:pharmacology; D012680:Sensitivity and Specificity; D013629:Tamoxifen / Q000494:pharmacology
chemical_list: D003271:Contraceptive Agents, Female; D012739:Gonadal Steroid Hormones; D006728:Hormones; D009652:Norpregnenes; D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen; D016912:Levonorgestrel; C027385:tibolone